Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes

Excerpts from the United States Renal Data System, United States Renal Data System, 1995, Annual Report, Am J Kid Dis, 26, S85

Churchill, 1993, Comparative morbidity among hemodialysis and continuous ambulatory peritoneal dialysis patients, Kidney Int, 43, S16

Canada-usa (Canusa) Peritoneal Dialysis Study Group, 1996, Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes, J Am Soc Nephrol, 7, 198, 10.1681/ASN.V72198

Lemmers, 1991, Major role for arterial disease in morbidity and mortality after kidney transplantation in diabetic recipients, Diabetes Care, 14, 295, 10.2337/diacare.14.4.295

Kasiske, 1996, Cardiovascular disease after renal transplantation, J Am Soc Nephrol, 7, 158, 10.1681/ASN.V71158

Wilson, 1987, Coronary risk prediction in adults (the Framingham Heart Study), Am J Cardiol, 59, 91G, 10.1016/0002-9149(87)90165-2

Ma, 1992, Cardiovascular risk factors in chronic renal failure and hemodialysis populations, Am J Kid Dis, 19, 505, 10.1016/S0272-6386(12)80827-4

Rostand, 1982, Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease, Kidney Int, 22, 304, 10.1038/ki.1982.170

Cressman, 1992, Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients, Circulation, 86, 475, 10.1161/01.CIR.86.2.475

Wu, 1983, Cardiovascular deaths among CAPD patients, Perit Dial Bull, 4, S23, 10.1177/089686088300303S07

Foley, 1996, Impact of hypertension on cardiomyopathy, morbidity, and mortality in end-stage renal disease, Kidney Int, 49, 1379, 10.1038/ki.1996.194

Bostom, 1996, Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: A matched case-control study, Atherosclerosis, 125, 91, 10.1016/0021-9150(96)05865-0

Mccully, 1969, Vascular pathology of homocysteinemia: implications for pathogenesis of arteriosclerosis, Am J Pathol, 56, 111

Stampfer, 1992, A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians, JAMA, 268, 877, 10.1001/jama.1992.03490070059042

Bostom AG, Shemin D, Verhoef P, Nadeau MR, Jacques PF, Seliiub J, Dworkin L, Rosenberg IH: Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study. Arteriosclerosis Thromb Vasc Biol (in press)

Brosnan, 1987, The 1986 Borden Award Lecture. The role of the kidney in amino acid metabolism and nutrition, Can J Physiol Pharmacol, 65, 2355, 10.1139/y87-373

Tizianello, 1980, Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency, J Clin Invest, 65, 1162, 10.1172/JCI109771

Flugel-Link, 1983, Red cell and plasma amino acid concentrations in renal failure, J Paren Ent Nutr, 7, 450, 10.1177/0148607183007005450

Laidlaw, 1994, Patterns of fasting plasma amino acid levels in chronic renal insufficiency: Results from the feasibility phase of the Modification of Diet in Renal Disease Study, Am J Kid Dis, 23, 504, 10.1016/S0272-6386(12)80371-4

Bostom, 1995, Net uptake of plasma homocysteine by the rat kidney in vivo, Atherosclerosis, 116, 59, 10.1016/0021-9150(95)05522-X

Selhub, 1992, The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by s-adenosylmethionine of the remethylation and transsulfuration of homocysteine, Am J Clin Nutr, 55, 131, 10.1093/ajcn/55.1.131

Mckeever, 1991, Betaine: Homocysteine methyltransferase: organ distribution in man, pig, and rat and subcellular distribution in the rat, Clin Sci, 81, 551, 10.1042/cs0810551

Ueland, 1993, Total homocysteine in plasma or serum: methods and applications, Clin Chem, 39, 1764, 10.1093/clinchem/39.9.1764

Mudd, 1989, Disorders of transsulfuration, 693

Rosenblatt, 1989, Inherited disorders of folate transport and metab olism, 2049

Linnell, 1995, Inherited disorders of cobalamin metabolism and their management, Ballières Clin Haematol, 8, 567, 10.1016/S0950-3536(05)80221-5

Brattstrom, 1989, Plasma homocysteine and methionine tolerance in early-onset vascular disease, Haemostasis, 19, 35

Miller, 1994, Folate deficiency-induced homocysteinemia in rats: Disruption of S-adenosylmethionine's coordinate regulation of homocysteine metabolism, Biochem J, 298, 415, 10.1042/bj2980415

Miller, 1994, Vitamin B-6 deficiency vs. folate deficiency: comparison of responses to methionine loading in rats, Am J Clin Nutr, 59, 1033, 10.1093/ajcn/59.5.1033

Bostom, 1995, Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study, Atherosclerosis, 116, 147, 10.1016/0021-9150(95)05529-6

Bostom, 1995, Validation of abbreviated oral methionine loading test, Clin Chem, 41, 948, 10.1093/clinchem/41.6.948

Selhub, 1993, Vitamin status and intake as primary determinants of homocysteinemia in an elderly population, JAMA, 270, 2693, 10.1001/jama.1993.03510220049033

Jacques, 1996, Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations, Circulation, 93, 7, 10.1161/01.CIR.93.1.7

Goyette, 1994, Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping, and mutation identification, Nature Genet, 7, 195, 10.1038/ng0694-195

Frosst, 1995, A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase, Nature Genet, 10, 111, 10.1038/ng0595-111

Brattstrom, 1994, Homocysteine and cysteine: Determinants of plasma levels in middle-aged to elderly subjects, J Intern Med, 236, 633, 10.1111/j.1365-2796.1994.tb00856.x

Araki, 1989, Plasma sulfhydryl amino acids in patients with cerebral infarction and in hypertensive subjects, Atherosclerosis, 79, 139, 10.1016/0021-9150(89)90118-4

Wu, 1994, Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease, Clin Chem, 40, 552, 10.1093/clinchem/40.4.552

Lussier-Cacan, 1996, Plasma total homocysteine in healthy subjects: Sexspecific relation with biological traits, Am J Clin Nutr, 64, 587, 10.1093/ajcn/64.4.587

Mudd, 1975, Labile methyl balances for normal humans on various dietary regimens, Metabolism, 24, 721, 10.1016/0026-0495(75)90040-2

Lindgren, 1995, Plasma homocysteine in the acute and convalescent phases after stroke, Stroke, 26, 795, 10.1161/01.STR.26.5.795

Robins, 1972, Plasma amino acid abnormalities in chronic renal failure, Clin Chim Acta, 42, 215, 10.1016/0009-8981(72)90401-9

Cohen, 1977, Alternate reasons for atherogenesis in uremia, Proc Dial Transplant Forum, 7, 178

Wilcken, 1979, Sulphur-containing amino acids in chronic renal failure with particular reference to cysteine-homocysteine mixed disulfide, Eur J Clin Invest, 9, 301, 10.1111/j.1365-2362.1979.tb00888.x

Wilcken, 1980, Accumulation of sulphur-containing amino acids including cysteine-homocysteine mixed disulfide in patients on hemodialysis, Clin Sci, 58, 427, 10.1042/cs0580427

Wilcken, 1981, Homocysteine in the plasma of renal transplant recipients: Effects of cofactors for methionine metabolism, Clin Sci, 61, 743, 10.1042/cs0610743

Kang, 1983, Plasma protein-bound homocyst(e)ine in patients requiring chronic hemodialysis, Clin Sci, 65, 335, 10.1042/cs0650335

Smolin, 1987, Altered plasma free and protein-bound sulfur amino acid levels in patients undrgoing maintenance hemodialysis, Am J Clin Nutr, 45, 731, 10.1093/ajcn/45.4.737

Chauveau, 1993, Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients, Kidney Int, 43, S72

Hultberg, 1993, Plasma homocysteine in renal failure, Clin Nephrol, 40, 230

Stabler, 1993, Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency, Blood, 81, 3404, 10.1182/blood.V81.12.3404.3404

Kim, 1994, Hyperhomocysteinemia as a possible role for atherosclerosis in CAPD patients, Adv Perit Dial, 10, 282

Massy, 1994, Hyperhomocysteinemia: A significant risk factor for cardiovascular disease in renal transplant recipients, Nephrol Dial Transplant, 9, 1103, 10.1093/ndt/9.8.1103

Bostom, 1995, Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: A case control study, Atherosclerosis, 114, 93, 10.1016/0021-9150(94)05470-4

Perna, 1995, Mechanism of erythrocyte accumulation of methylation inhibitor s-adenosylhomocysteine in uremia, Kidney Int, 47, 247, 10.1038/ki.1995.31

Bachmann, 1995, Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients, J Am Soc Nephrol, 6, 121, 10.1681/ASN.V61121

Arnadottir, 1996, Hyperhomocysteinemia in cyclosporine-treated renal trans plant recipients, Transplantation, 61, 509, 10.1097/00007890-199602150-00034

Robinson, 1996, Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations, Circulation, 94, 2743, 10.1161/01.CIR.94.11.2743

Descombes, 1993, Water soluble vitamins in chronic hemodialysis patients and need for supplementation, Kidney Int, 43, 1319, 10.1038/ki.1993.185

Spannuth, 1977, Increased plasma clearance of pyridoxal 5′-phosphate in vitamin B-6 deficient uremic man, J Lab Clin Invest, 90, 632

Wei, 1995, Activities of hepatic vitamin B-6 metabolizing enzymes and concentrations of vitamin B-6 vitamers in tissues of chronically azotemic rats, J Nutr Biochem, 6, 494, 10.1016/0955-2863(95)00079-F

Bostom, 1996, Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients, Atherosclerosis, 123, 193, 10.1016/0021-9150(96)05809-1

Janssen, 1996, Folic acid treatment of hyperhomocysteinemia in dialysis patients, Miner Electrol Metab, 22, 110

Bostom, 1996, Brief report: Lack of effect of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patients, Atherosclerosis, 120, 242, 10.1016/0021-9150(95)05705-6

Zazgornik, 1982, Diminished serum folic acid levels in renal transplant recipients, Clin Nephrol, 18, 306

Lacour, 1983, Pyridoxal 5′-phosphate deficiency in uremic undialyzed, hemodialyzed, and non-uremic kidney transplant patients, Clin Chim Acta, 127, 205, 10.1016/S0009-8981(83)80005-9

Stabler, 1988, Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using gas chromatography-mass spectrometry, Anal Biochem, 162, 186

Brattstrom, 1992, Hyperhomocysteinemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors, Eur J Clin Invest, 22, 214, 10.1111/j.1365-2362.1992.tb01829.x

Guttormsen, 1996, Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency, Am J Clin Nutr, 63, 194, 10.1093/ajcn/63.2.194

Foreman, 1982, Homocysteine uptake in isolated rat renal cortical tubules, Metabolism, 31, 613, 10.1016/0026-0495(82)90101-9

Bocock, 1990, Hepatic sulfur amino acid metabolism in rats with chronic renal failure, J Nutr, 120, 691, 10.1093/jn/120.7.691

Gutformsen AB, Ueland PM, Svarstad E, Refsum H: The kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int (in press)

Sturman, 1976, Activities of some enzymes involved in homocysteine methylation in brain, liver, and kidney of the developing rhesus monkey, J Neurochem, 27, 425, 10.1111/j.1471-4159.1976.tb12264.x

Gaull, 1973, Development of methyltransferase activities of human fetal tissues, Pediatr Res, 7, 527, 10.1203/00006450-197305000-00006

Sturman, 1970, Distribution of transsulfuration enzymes in various organs and species, Int J Biochem, 1, 251, 10.1016/0020-711X(70)90102-3

Van Guldener, 1995, Short term effect of kidney transplantation on plasma homocysteine in dialysis patients, Irish J Med Sci, 164, 22

Arnadottir, 1996, The effect of reduced glomerular filtration rate on plasma total homocysteine concentration, Scand J Clin Lab Invest, 56, 41, 10.3109/00365519609088586

Cockroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16

Boushey, 1995, A quantitative assessment of plasma homocysteine as a risk factor for vascular disease, JAMA, 274, 1049, 10.1001/jama.1995.03530130055028

Arnesen, 1995, Serum total homocysteine and coronary heart disease, Int J Epidemiol, 24, 704, 10.1093/ije/24.4.704

Perry, 1996, Serum total homocysteine and coronary heart disease in middle-aged British men, Heart, 75, P53

Perry, 1995, Prospective study of serum total homocysteine and risk of stroke in middle-aged British men, Lancet, 346, 1395, 10.1016/S0140-6736(95)92407-8

Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GHJ, Sheahan RG, Israelson B, Uiterwaal CS, Meleady RM: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA (in press)

Harker, 1976, Homocystineinduced arteriosclerosis. The role of endothelial injury and platelet response in its genesis, J Clin Invest, 58, 731, 10.1172/JCI108520

Wall, 1980, Homocystineinduced endothelial injury in vitro: A model for the study of vascular injury, Thromb Res, 18, 113, 10.1016/0049-3848(80)90175-9

Heinecke, 1987, The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells, J Biol Chem, 262, 10098, 10.1016/S0021-9258(18)61082-8

Di Minno, 1993, Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol sensitive mechanism, J Clin Invest, 92, 1400, 10.1172/JCI116715

Lentz, 1991, Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine, J Clin Invest, 88, 1906, 10.1172/JCI115514

Harpel, 1992, Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein (a) to fibrin: A potential link between thrombosis, atherogenesis, and sulfhydryl compound metabolism, Proc Natl Acad Sci USA, 89, 10193, 10.1073/pnas.89.21.10193

Tsai, 1994, Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis, Proc Natl Acad Sci USA, 91, 6369, 10.1073/pnas.91.14.6369

Dudman, 1991, Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine, Atherosclerosis, 91, 77, 10.1016/0021-9150(91)90189-A

Wang, 1993, Effects of homocysteine and related compounds on prostacyclin production by cultured human vascular endothelial cells, Thromb Haemost, 70, 1047, 10.1055/s-0038-1649723

Mansoor, 1993, Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria, Metabolism, 42, 1481, 10.1016/0026-0495(93)90202-Y

Rolland, 1995, Hyperhomocyst(e)inemia-induced vascular damage in the minipig, Circulation, 91, 1161, 10.1161/01.CIR.91.4.1161

Lentz, 1996, Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia, J Clin Invest, 98, 24, 10.1172/JCI118771

Mudd, 1985, The natural history of homocystinuria due to cystathionine beta-synthase deficiency, Am J Hum Genet, 37, 1

Brattstrom, 1988, Folic acidan innocuous means to reduce plasma homocysteine, Scand J Clin Lab Invest, 48, 215, 10.3109/00365518809167487

Glueck, 1995, Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients, 132

Ubbink, 1993, Vitamin B-12, vitamin B-6, folate nutritional status in men with hyperhomocysteinemia, Am J Clin Nutr, 57, 47, 10.1093/ajcn/57.1.47

Ubbink, 1994, Vitamin requirements for the treatment of hyperhomocysteinemia in humans, J Nutr, 124, 1927, 10.1093/jn/124.10.1927

Landgren, 1995, Plasma homocysteine in acute myocardial infarction: Homocysteine-lowering effect of folic acid, J Intern Med, 237, 381, 10.1111/j.1365-2796.1995.tb01190.x

Brattstrom, 1988, Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta synthase deficiency, Metabolism, 37, 175, 10.1016/S0026-0495(98)90014-2

Brattstrom, 1990, Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: Effects of pyridoxine and folic acid treatment, Atherosclerosis, 81, 51, 10.1016/0021-9150(90)90058-Q

Franken, 1994, Effect of various regimens of vitamin B-6 and folic acid on mild hyperhomocysteinemia in vascular patients, J Inherit Metab Dis, 17, 159, 10.1007/BF00735426

Ubbink, 1996, The effect of a subnormal vitamin B-6 status on homocysteine metabolism, J Clin Invest, 98, 177, 10.1172/JCI118763

Bostom, 1996, High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients, Kidney Int, 49, 147, 10.1038/ki.1996.19

Wilcken, 1988, Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular disease, Metabolism, 37, 697, 10.1016/0026-0495(88)90093-5

Arnadottir, 1993, The effect of high dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients, Clin Nephrol, 40, 236

Chauveau, 1996, Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure, Miner Electrol Metab, 22, 106

Bostom, 1995, Short term betaine therapy fails to lower elevated fasting total plasma homocysteine levels in hemodialysis patients maintained on chronic folic acid supplementation, Atherosclerosis, 113, 129, 10.1016/0021-9150(94)05466-V

Dennis, 1996, Homocysteinemia and vascular disease in end-stage renal disease, Kidney Int, 50, S11

Bergström, 1995, Nutrition and mortality in hemodialysis, J Am Soc Nephrol, 6, 1329, 10.1681/ASN.V651329